Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Dermatologic 1

Conditions

Sarcoma 3Rectal Neoplasms 3Colonic Neoplasms 3Unspecified Adult Solid Tumor, Protocol Specific 2Melanoma 2Colorectal Neoplasms 2Uterine Cervical Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Solitary Fibrous Tumor, Pleural 1Skin Neoplasms 1Peritoneal Neoplasms 1Ovarian Neoplasms 1Neoplasms, Unknown Primary 1Nasopharyngeal Neoplasms 1Mesothelioma, Malignant 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Acute 1Head and Neck Neoplasms 1Gastrointestinal Stromal Tumors 1Fallopian Tube Neoplasms 1Carcinoma, Renal Cell 1Anemia, Refractory, with Excess of Blasts 1

Interventions

Trastuzumab 2Paclitaxel 2Leucovorin 2Fluorouracil 2Carboplatin 2veliparib 1tipifarnib 1entinostat 1Vincristine 1Taxes 1Semaxinib 1Oxaliplatin 1Interleukin-12 Subunit p35 1Interleukin-12 1Floxuridine 1Etoposide 1Epirubicin 1Doxorubicin 1Cyclophosphamide 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Neoplasms, Unknown Primary × Semaxinib × Clear all
NCT00006361 2009-12-04

SU5416 in Treating Patients With Advanced or Recurrent Cancer of the Head and Neck

National Cancer Institute (NCI)

Phase 2 Completed
DermatologicHead & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Nasopharyngeal Neoplasms, Neoplasms, Unknown Primary, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡